PS.

Meningitis B vaccine (2026)

UK HEALTH AND SECURITY AGENCYcontractFind a Tender ↗Ref ocds-h6vhtk-059678Procurement Act 2023pending

Estimated value

—

Awarded value

—

Suppliers

1

Lots

1

1 awarded

Published

09 Sept 2025

Description

The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea. This notice provides an indication to the market of UKHSA's intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the meningococcal group B vaccine, in accordance with JCVI advice.

Scope

Reference
C352798
Commercial tool
Standalone contract

Submission & procedure

Procedure
Direct award

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

30 Sept 2026

Contract end

30 Sept 2028

Awarded to
GU
GlaxoSmithKline UK Limited